Epigenetic readers recognize
modified amino acids in histone proteins to cause changes in gene expression. Readers
containing bromodomains, which recognize acetylated lysine residues, have
received particular attention, and fragment-based approaches have led to at
least a couple bromodomain inhibitors entering clinical development. But the
numerous bromodomains are not the only epigenetic readers to recognize
acetylated lysine residues. In a recent paper in J. Med. Chem., Apirat Chaikuad, Stefan Knapp, and collaborators at
Goethe-University Frankfurt and University of Oxford describe their efforts
targeting a different family.
YEATS domains are present in four
human proteins, three of which have been linked to cancer. Unlike bromodomains,
YEATS domains recognize lysine residues modified with acyl derivatives beyond
acetyl, such as propionyl, butyryl, and crotonyl. The biological significance
of these modifications is not clear, and no inhibitors of these proteins had
been reported when the work began.
The researchers focused on the
oncogenic eleven-nineteen-leukemia protein (ENL). They solved the first apo
crystal structure of ENL (ie, without a bound ligand), which revealed that
although the binding pocket was pre-formed, there was some flexibility in the
side chain residues. They also noted distinct differences in how the acylated
lysine is recognized, including the absence of an asparagine residue that is conserved
in all bromodomains, and a more-open pocket that can accommodate larger acyl
chains.
Next, the researchers chose a set
of nineteen fragments containing a central amide bond to mimic acetylated lysine.
None of these showed activity in a thermal shift assay, but when the ligands
were soaked (at 5-40 mM) into crystals of ENL, electron density consistent with
binding was observed for ten of them, and two could be modeled with some
confidence. (For the other nine compounds, the crystals no longer diffracted.) These
two fragments also showed binding by isothermal titration calorimetry (ITC). This
is a useful reminder of the need for orthogonal assays, and the power of crystallography
to detect weak hits. Compound 19, a rather super-sized fragment, was similar to
compounds identified in a high-throughput screen that the researchers reported here and here.
Using this information, the
researchers made a handful of analogs and found that compound 20 had high
nanomolar affinity as assessed by ITC. Like last week’s story, this effort could
probably be considered more fragment-assisted than fragment-based. But whatever
the precise genealogy, hopefully molecular descendants of compound 20 will help to elucidate
the biological poetry of the YEATS domains.
No comments:
Post a Comment